27M01: Plenary II (0849–0854)

Abstract Moderator(s)

• SS

  Susan Shenoi, MS, MBBS, RhMSUS

  Seattle Children's Hospital and Research Center
  Mercer Island, Washington, United States

  Disclosure information not submitted.
• MJ

  Matlock Jeffries, MD, FACP, FACR

  Oklahoma Medical Research Foundation
  Oklahoma City, OK, United States

  Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

• 8:00 AM - 8:15 AM Central Time

  Mortality and Major Adverse Cardiac Events (MACE) with GLP-1 Receptor Agonists in Psoriatic Arthritis
  

  Presenting Author: Nanuka Tsibadze, MD – Jefferson Health - Einstein
• 8:15 AM - 8:30 AM Central Time

  Single-cell RNA-seq analysis of synovial CD4⁺ T cells identifies a novel biomarker and therapeutic target in human rheumatoid arthritis
  

  Presenting Author: Akinori Murakami, MD – Kyoto University
• 8:30 AM - 8:45 AM Central Time

  Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis
  

  Presenting Author: Andrea Fava, MD – Johns Hopkins University
• 8:45 AM - 9:00 AM Central Time

  LEVI-04 Significantly Reduces Bone Marrow Lesions and Symptoms in Knee Osteoarthritis: Results from a Phase II RCT
  

  Presenting Author: Simon Westbrook, PhD – Levicept Ltd
• 9:00 AM - 9:15 AM Central Time

  Olink Proteomics Identifies Macrophage Pro-inflammatory Proteins in Maternal Sera Predictive of Fetal Atrioventricular Block Independent of Maternal Health Status
  

  Presenting Author: Philip Carlucci, MD – New York University School of Medicine
• 9:15 AM - 9:30 AM Central Time

  The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception Cohort Study
  

  Presenting Author: Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta